LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 41.68 | 21.74 | 1143 | 3418 | 0.3343 | 0.7212 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.65 | 21.74 | 1 | 3754 | 0.0003 | -0.3392 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.65 | 21.74 | 1081 | 3754 | 0.2879 | 0.6915 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.65 | 21.74 | 21 | 3754 | 0.0056 | -0.0046 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 43.65 | 21.74 | 1205 | 3754 | 0.3210 | 0.7164 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.62 | 21.74 | 1 | 4150 | 0.0002 | -0.3339 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.62 | 21.74 | 1071 | 4150 | 0.2580 | 0.6726 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.62 | 21.74 | 22 | 4150 | 0.0053 | 0.0016 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 45.62 | 21.74 | 1179 | 4150 | 0.2840 | 0.6939 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.59 | 21.74 | 1 | 4492 | 0.0002 | -0.3299 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.59 | 21.74 | 1079 | 4492 | 0.2402 | 0.6615 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.59 | 21.74 | 14 | 4492 | 0.0031 | -0.0556 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.59 | 21.74 | 1235 | 4492 | 0.2749 | 0.6909 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.56 | 21.74 | 2 | 4838 | 0.0004 | -0.2636 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.56 | 21.74 | 1133 | 4838 | 0.2342 | 0.6603 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.56 | 21.74 | 17 | 4838 | 0.0035 | -0.0310 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.56 | 21.74 | 1253 | 4838 | 0.2590 | 0.6818 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.53 | 21.74 | 3 | 5150 | 0.0006 | -0.2220 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.53 | 21.74 | 1182 | 5150 | 0.2295 | 0.6596 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.53 | 21.74 | 22 | 5150 | 0.0043 | 0.0015 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.53 | 21.74 | 1272 | 5150 | 0.2470 | 0.6751 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.50 | 21.74 | 5 | 5425 | 0.0009 | -0.1685 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.50 | 21.74 | 1209 | 5425 | 0.2228 | 0.6563 | MN20160310_N01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.50 | 21.74 | 22 | 5425 | 0.0041 | 0.0015 | MN20160310_N01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.50 | 21.74 | 1285 | 5425 | 0.2368 | 0.6691 | MN20160310_N01 | I20 |